SAFE: an important partner in new research to prevent complications after stroke.

Published date
Thursday, 30 July, 2015

Published: Thursday 30 July 2015

Stroke is the world’s second largest cause of death and is the number one cause of long term severe disability.

The European Commission has funded a new research project in stroke under its Horizon 2020 programme.

The PRECIOUS project will examine the consequences of treating complications of stroke such as infections or fever or swallowing problems, all of which commonly occur in elderly patients. Failing to treat these complications often leads to a worse outcome overall.

The study

A total of 6 million Euros (over £4 million) has been awarded to the consortium to run the trial over 5 years. The project includes SAFE (Stroke Alliance for Europe) and partners from 10 other European countries. PRECIOUS will recruit 3800 patients in 80 hospitals to the study. Patients over the age of 66 will be screened and, if found suitable, will be given cheap off-the-shelf drugs in the first four days of their hospitalization.

The PRECIOUS consortium is led by Neurologist Bart van der Worp of UMC Utrecht, Netherlands. SAFE will contribute to dissemination of the project.

Jon Barrick, President of SAFE commented “Stroke research is hugely underfunded and so we are pleased to support PRECIOUS. This simple but necessary study by leading European clinicians will help inform future practice and provide better outcomes”

Coordinator Bart van der Worp on the benefits of the project:
"Our aim is that this project will demonstrate the big potential of health benefits that can be achieved for the European people - at relatively low cost. The hope is that with a preventive treatment with cheap and safe drugs the chances of good recovery after a stroke increase, both within Europe and beyond. "

About Horizon 2020 Programme

Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly €80 billion (approx. £60 billion) of funding available over 7 years (2014 to 2020). It promises more breakthroughs, discoveries and world-firsts by taking great ideas from the lab to the market.

About SAFE

SAFE is the leading European network of stroke support organisations. It is a non-profit organisation and has 26 member organisations spread over 22 countries. SAFE represents a range of patient groups whose aims include driving stroke prevention up the European political agenda, supporting stroke research and the prevention of stroke through improved education.  For more information about SAFE visit the website:

Press contact

Contact Dr. Gary Randall ( for further information on PRECIOUS

News type